Cancer Drugs: Greener Pastures for Pharma R&D and Wall Street
Two news items regarding medical/pharmaceutical research caught my attention today. Both involve stem cells.
The first item was about research results revealed at the American...
Occupy Pfizer! Protest It’s Deal to Block Sales of Generic Lipitor! #OccupyPFE
"I'm mad as hell and I'm not going to take this any more!"
I love that line from the 1976 movie Network. The whole scene...
Buzz ‘n Blog Pharma Marketing Survey
This surevy solicits your opinion on specific marketing tactics involving CGC and buzz, specifically from a pharmaceutical marketing point of view.
Should Free Drug Samples Be Banned?
While the new PhRMA Code on Interactions with Healthcare Professionals bans free pens and lunches, it doesn't apply to samples. Should free drug samples also be banned? Take our survey and give us your opinion.
Are Pharma Reps Important to Docs or Not?
One survey says yes, pharma reps are important to physicians, another says not so much. Who are we to believe?
Pharma Turns Up Heat to Unchill Off-Label “Free Speech”
The drug industry brings legal heat to the issue of off-label drug promotion.
Pharma YouTube Patient Videos Lack Transparency
Pharma social networking sites like Facebook and YouTube may lack patient-centered information and can also be sources of misleading information that could potentially do more harm than good.
Pfizer’s Chapstick Slapstick Facebook Fiasco
If pharma marketers are going to be successful engaging consumers (mostly women) via social media, then they need to be more sensitive about how they portray women in ads and very savvy about how they handle comments (if they allow comments).
Johnson & Johnson’s ennTV
A conversation with Michael Heinley, Corporate Vice President, Leadership and Employee Communication, and Bill Price, Vice President, Media Relations, Johnson & Johnson, about the company's Employee News Network (
Maximizing Stakeholder Effectiveness
A summary of the highly anticipated 2011 results of Kantar Health's annual Stakeholder Effectiveness survey, which revealed that over two-thirds of respondents from leading companies in the pharmaceutical sector think that customer retention is a key performance measure.










